WAYCO AI, INC.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
WAYCO AI, INC. - overview
Established
2025
Location
New York, NY-New York, US
Primary Industry
Software
About
Wayco AI, Inc. is a U. S. -based enterprise that leverages artificial intelligence to enhance medical-legal case management, streamlining processes to connect patients with appropriate medical providers efficiently.
Founded in 2025 and headquartered in New York, US, Wayco AI specializes in providing AI solutions for managing medical-legal cases. The founder's history is not detailed, nor are there known subsidiaries or significant changes in business strategy. The company engaged in a Seed funding round in February 2026, marking its first investment target with a single deal. Wayco AI offers an advanced platform designed to enhance medical-legal case management by utilizing artificial intelligence to streamline processes from intake to patient-provider matching.
The core product enables med-legal professionals to efficiently manage medical cases with features such as automated case reviews, lead management, and voice AI for seamless communication. This technology aids in analyzing thousands of cases simultaneously, facilitating the connection of patients to suitable medical providers based on their treatment requirements and geographical proximity. Wayco AI primarily serves clients in personal injury law, medical insurance, and mass torts, targeting markets across the United States and Canada. The platform integrates into existing workflows, enhancing collaboration between medical-legal professionals and technology to ensure optimal outcomes for patients.
Wayco AI's revenue model is centered around subscription-based services, providing clients with access to their AI-powered med-legal platform. Clients, including law firms and medical providers, engage in business transactions through annual or monthly subscriptions, which may include tiered pricing based on the number of cases managed or features utilized. The flagship offerings, such as the case intake and patient matching functionalities, form the backbone of their service and are integral to the value proposition presented to clients. By leveraging the Wayco AI platform, clients can optimize their operations, potentially resulting in enhanced revenue generation through improved case management efficiencies and faster lead responses.
In February 2026, Wayco AI raised an undisclosed amount of Seed funding from investors Y Combinator and Pioneer Fund, which will be utilized to expand its product offerings and enhance the platform's capabilities. The company aims to launch new features focused on improving user experience and efficiency in case management. Additionally, Wayco AI plans to target expansion into new markets, specifically in Canada and other regions of North America, by mid-2027.
Current Investors
Y Combinator, Pioneer Fund
Primary Industry
Software
Sub Industries
Healthcare IT, Medical Software
Website
wayco.ai
Verticals
Artificial Intelligence, Cloud Computing, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
WAYCO AI, INC. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Seed | Completed | WAYCO AI, INC. | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.